Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

URGN

UroGen Pharma Ltd

May 15 • 12:15PM ET

28.37

-1.31 -4.42 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: IBRX TARA CGEN VERU FATE

| Held by: IWM IBB IWO SPDW FESM VTWO IWC IZRL CANC VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.75	Insider Own	20.85%	Shs Outstand	48.71M	Perf Week	-3.51%
Market Cap	1.38B	Forward P/E	19.74	EPS next Y	1.44	Insider Trans	-0.34%	Shs Float	38.56M	Perf Month	32.63%
Enterprise Value	1.44B	PEG	-	EPS next Q	-0.29	Inst Own	81.79%	Short Float	18.77%	Perf Quarter	41.14%
Income	-133.23M	P/S	9.84	EPS this Y	72.25%	Inst Trans	3.73%	Short Ratio	8.13	Perf Half Y	12.85%
Sales	140.49M	P/B	-	EPS next Y	262.32%	ROA	-53.15%	Short Interest	7.24M	Perf YTD	21.13%
Book/sh	-2.55	P/C	9.76	EPS next 5Y	-	ROE	-	52W High	32.37 -12.36%	Perf Year	188.01%
Cash/sh	2.91	P/FCF	-	EPS past 3/5Y	12.81% 11.57%	ROIC	-187.84%	52W Low	3.42 729.51%	Perf 3Y	140.22%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	19.49% 56.22%	Gross Margin	89.85%	Volatility	9.10% 7.70%	Perf 5Y	86.64%
Dividend TTM	-	EV/Sales	10.23	EPS Y/Y TTM	13.32%	Oper. Margin	-77.02%	ATR (14)	1.92	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.28	Sales Y/Y TTM	52.92%	Profit Margin	-94.83%	RSI (14)	60.82	Recom	1.22
Dividend Gr. 3/5Y	- -	Current Ratio	4.69	EPS Q/Q	49.18%	SMA20	8.70%	Beta	1.62	Target Price	36.11
Payout	-	Debt/Eq	-	Sales Q/Q	151.60%	SMA50	29.48%	Rel Volume	0.41	Prev Close	29.68
Employees	291	LT Debt/Eq	-	Earnings	May 06 BMO	SMA200	35.19%	Avg Volume	890.26K	Price	28.37
IPO	May 04, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.57% 13.68%	Trades		Volume	166,721	Change	-4.42%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)